TSX VENTURE COMPANIES THREE VALLEY COPPER CORP. (“TVC.WT“)BULLETIN TYPE: Warrant Expiry-DelistBULLETIN DATE: January 31, 2022TSX Venture Tier 2 Company Effective at the opening, February 7, 2022, the Share...
BrandSpark International and Newsweek have just announced the winners of the 2022 Best New Product Awards, America’s most credible new product awards. More than 11,000 Americans...
4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company”), a vertically integrated, multi-state cannabis operator and retailer, today announced it has closed on the...
TPCO Holding Corp. (“The Parent Company” or the “Company”) (NEO: GRAM.U) (OTCQX: GRAMF), a leading vertically-integrated California cannabis company, announced today that certain insiders (the “Insiders”) have...
Starting this week, Canadian beauty lovers can stock up on one of the most popular skincare brands in the world – Drunk Elephant – at...
Apollon Formularies plc (AQSE: APOL) (“Apollon” or the “Company”), a UK based international medical cannabis pharmaceutical company trading on AQSE Growth Market, is pleased to announce the appointment of Dr. Herbert Fritsche to...
Brains Bioceutical Corp. (“Brains Bio” or the “Company”) through its wholly-owned subsidiary BSPG Laboratories ltd (“BSPG”), is pleased to announce it has received confirmation of validation from the United...
Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics...
Apollon Formularies plc (AQSE: APOL) , (“Apollon” or the “Company”), a UK based international pharmaceutical company specializing in medical cannabis and trading on AQSE Growth Market, is pleased to release...
Medicinal cannabis, CBD and hemp healthcare products company, Bod Australia Limited (“Bod”, or “the Company”), has partnered with UK’s leading independent scientific body on drugs,...